Shingo Kurahashi

A novel STAT inhibitor, OPB-31121, has a significant antitumor effect on leukemia with STAT-addictive oncokinases

Fumihiko Hayakawa, Keiji Sugimoto, Yasuo Harada et al. · Blood Cancer Journal · 2013 · 108 citations · Full text

Medicine, Oncology, Pharmacology +14

B Cell Receptor-ERK1/2 Signal Cancels PAX5-Dependent Repression of BLIMP1 through PAX5 Phosphorylation: A Mechanism of Antigen-Triggering Plasma Cell Differentiation

Takahiko Yasuda, Fumihiko Hayakawa, Shingo Kurahashi et al. · The Journal of Immunology · 2012 · 43 citations

Life Sciences, Immunology, Molecular Biology +17

PAX5–PML acts as a dual dominant-negative form of both PAX5 and PML

Shingo Kurahashi, Fumihiko Hayakawa, Yasuyoshi Miyata et al. · Oncogene · 2011 · 42 citations

Life Sciences, Cell Biology, Molecular Biology +3

Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study

Masataka Kuwana, Tomoki� Ito, Shugo Kowata et al. · British Journal of Haematology · 2022 · 26 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan

Chika Kawajiri‐Manako, Emiko Sakaida, Chikako Ohwada et al. · Biology of Blood and Marrow Transplantation · 2018 · 25 citations · Full text

Medicine, Hematology, Cell Therapy +10